This Month Year to Date All Time Custom
Highlight search results
Danish
German
English
French
Italian
Dutch
Toggle Columns
Type
Order
Decision
Reference
Court Division
Brüssel
Brussels
Copenhagen
Den Haag
Düsseldorf
Hamburg
Helsinki
Lisbon
Lissabon
Luxembourg
Luxemburg
Mailand
Mannheim
Milan
München
Munich
Nordic Baltic Regional Division
Paris
The Hague
Vienna
Tags
5 June, 2025
Order
ORD_26713/2025 Luxemburg (LU) EP2196231
R. 365 RoP
...

Please log in to add tags.

Please log in to add notes.

Please log in to add tags.

ORD_26713/2025
5 June, 2025
Order

Summary
(AI generated)

Parties

Tandem Diabetes Care Europe B.V.,
Tandem Diabetes Care, Inc.,
EOFLOW Co., Ltd.
v. Insulet Corporation

Registry Information
Registry Number:

App_24411/2025

Court Division:

Luxemburg (LU)

Type of Action:

Application Rop 365

Language of Proceedings:

EN

Patent at issue

EP2196231

Sections

Headnotes (EN)

In principle, the costs of the proceedings are not covered by confidentiality under Rule 262A RoP or by the attorney-client privilege unless they are specifically indicative of the company's financial capacity, its commercial strategy, or the importance of the patent as a corporate asset.

Keywords (EN)

legal costs
Cited Legal Standards
R. 262.1(b) RoP
R. 262.2 RoP
R. 365.1 RoP
R. 365 RoP
Add a custom note or summary to this decision
Styles
Text
Heading 1
Heading 2
Heading 3
Bold ⌘B
Italic ⌘I
Strikethrough ⌘+Shift+S
Bullet list
Ordered list
Blockquote ⌘+Shift+B
Insert link ⌘K
Insert link
Unlink
Align
Left
Center
Right

ORD_26713/2025

UPC Court of Appeal UPC_CoA_120/2025 APL_7604/2025 App_24387/2025 App_24411/2025 App_24847/2025

ORDER

of the Court of Appeal of the Unified Patent Court issued on 3 June 2025 concerning a confirmation of a settlement

APPELLANTS (AND CLAIMANTS BEFORE THE COURT OF FIRST INSTANCE)

    1. Tandem Diabetes Care Europe B.V. , Schiphol Boulevard 359, WTC Schiphol Airport, D-Tower 11th floor, 1118 BJ, Schiphol, The Netherlands
    1. Tandem Diabetes Care, Inc. , 12400 High Bluff Drive, CA 92130, San Diego, USA

(hereinafter jointly referred to as 'Tandem Diabetes ')

both represented by attorney-at-law Christian Dekoninck, Taylor Wessing, Brussels, Belgium, and other representatives from that firm as well as from AOMB, Eindhoven, The Netherlands

RESPONDENT (AND DEFENDANT BEFORE THE COURT OF FIRST INSTANCE)

Roche Diabetes Care GmbH, Sandhofer Strasse 116, 68305, Mannheim, Germany

(hereinafter 'Roche Diabetes ')

represented by attorney-at-law Dr. Christof Augenstein, Kather Augenstein, Düsseldorf, Germany, and other representatives from that firm as well as from Grünecker Patent- und Rechtsanwälte, Munich, Germany

PATENT AT ISSUE

EP 2 196 231

PANEL AND DECIDING JUDGES

Panel 2

Rian Kalden, presiding judge and legally qualified judge Ingeborg Simonsson, legally qualified judge and judge-rapporteur Patricia Rombach, legally qualified judge Jeroen Meewisse, technically qualified judge Stefan Wilhelm, technically qualified judge

IMPUGNED DECISION OF THE COURT OF FIRST INSTANCE

Central Division Paris, 18 December 2024, revocation action ACT_589997/2023, UPC_CFI_454/2023

LANGUAGE OF THE CASE

English

SUMMARY OF FACTS

    1. Tandem Diabetes lodged an action for revocation of the patent at issue, relating to a system for ambulatory drug infusion, against Roche Diabetes before the Central Division Paris.
    1. In the impugned decision, the Central Division dismissed the revocation action, maintained the patent at issue as granted and ordered that the costs of the proceedings should be borne by Tandem Diabetes.
    1. Tandem Diabetes appealed. The parties then informed the Court that they had concluded the proceedings by way of settlement.

REQUESTS OF THE PARTIES

    1. Both parties request that the Court of Appeal
  • I. confirm that the parties have concluded the Settlement Agreement according to Annex BBY 1;
  • II. order that details of the settlement are confidential;
  • III. confirm that each party bears its own costs and that no costs shall be reimbursed between the parties.

REASONS

    1. According to R. 365 RoP, if requested by the parties, the Court shall confirm the settlement that they have reached. Such decision may be enforced as a final decision of the Court and shall be entered on the Register.
    1. The R. 262.2 RoP request will be decided once a R. 262.1(b) RoP request is made by a member of the public.
    1. The Settlement Agreement contains confidential information.

ORDER

  • I. At the request of the parties the Court of Appeal confirms, pursuant to R. 365.1 RoP, that the parties have concluded the following Settlement Agreement :

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

ORD_26713/2025

II. This settlement terminates the proceedings before the Court of Appeal pending under UPC_CoA_120/2025, APL_7604/2025.

III. The Court of Appeal confirms that each party shall bear its own costs and that no costs shall be reimbursed between the parties.

IV. This decision in the redacted version shall be entered on the register;

V. This decision is enforceable as a final decision of the Court of Appeal.

Issued on 3 June 2025

Rian Kalden, presiding judge and legally qualified judge

Ingeborg Simonsson, legally qualified judge and judge-rapporteur

Patricia Rombach, legally qualified judge

Jeroen Meewisse, technically qualified judge

Stefan Wilhelm, technically qualified judge

For the Registry

Showing 1 to 1 of 1 results
Subscription required
To use more advanced filters, you need an active subscription.